WHO Halts Hydroxychloroquine Trial Over Safety Concerns

The World Health Organization cited a scientific study published last week suggesting that proposed COVID-19 drug hydroxychloroqine may do more harm than good in halting its study to review data. The medical journal The Lancet reported on Friday that patients getting hydroxychloroquine were dying at higher rates than other coronavirus patients.  The WHO's trial had involved 3,500 patients from 17 countries 

WHO Halts Hydroxychloroquine Trial Over Safety Concerns The World Health Organization cited a scientific study published last week suggesting that proposed COVID-19 drug hydroxychloroqine may do more harm than good in halting its study to review data. The medical journal The Lancet reported on Friday that patients getting hydroxychloroquine were dying at higher rates than other coronavirus patients.  The WHO's trial had involved 3,500 patients from 17 countries  Read More You received this message because you're subscribed to Breaking News Alerts emails. This email was sent by National Public Radio, Inc., 1111 North Capitol Street NE, Washington, DC 20002 Unsubscribe  |  Privacy Policy